Devika Govind Das, MBBS

Devika Das practices at University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning.

Devika Das' NPI, 1922237486, was assigned on July 6, 2009. Devika Das graduated from Grant Medical College in 2007. Devika Das holds Florida license ME169982.

Devika Das' primary practice is University of Mississippi Medical Center, at 2500 N State St, Jackson, MS 39216 in Hinds County. The practice phone is (601) 984-4100.

Devika Das' primary practice is University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning. Devika Das is also affiliated with UF Health Shands Hospital. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Devika Das to 3 more medical groups and 1 behavioral health center, each named with a free account. Devika Das' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Devika Das practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Devika Das' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Devika Das is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Devika Das' licenses on file in 2 states: Florida and Alabama.

CMS data shows 188 Medicare services from Devika Das across 5 procedure codes in 2018, for 30 Medicare patients. Medicare paid $15,640 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 30 Medicare patients who saw Devika Das in 2024. The largest group is 75 to 84, with 12 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Devika Das' median patient age at 67, with 46% women.

In 2024, Devika Das wrote 52 Medicare Part D claims for 14 patients. 90% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $243 in total drug cost. In 2018, CMS named 33 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Devika Das for performance year 2024, reported through an alternative payment model (APM). Devika Das accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Devika Das as offering telehealth.

Dmand AI links 19 papers to Devika Das, published from 2020 to 2024. 2022 was the busiest year, with 5. The most frequent topics are COVID-19, Pandemics and Delivery of Health Care. Devika Das has published most often in JCO Oncol Pract. Devika Das' most frequent co-authors are Douglas W. Blayney, MD, Urshila Durani, MD and Haris Hatic, DO.

Dmand AI links Devika Das to 4 clinical trials. 4 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, COVID-19 and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 140 general payments to Devika Das from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $17,600.

Devika Das graduated from Grant Medical College in 2007.

Devika Das is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.